Data / Drug companies / Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited: 77 products in the FDA NDC directory, labeler code 14593
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Emcure Pharmaceuticals Limited (labeler code 14593) lists 77 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 76 bulk ingredients, 1 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on February 23, 2026.
The request: Watch Emcure Pharmaceuticals Limited (FDA labeler code 14593): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 14593
- Products in commercial distribution
- 77
- Packages
- 252
- Finished drugs by generic name
- 1
- Prescription products
- 1
- Over the counter products
- 0
- Controlled substance products
- Schedule III 1, Schedule IV 1
- Flagged as original packager
- 1 of 1 products that carry the flag
- Started marketing in the last 12 months
- 5
- Earliest marketing start
- June 27, 2008
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 76 | 98.7% |
| Generic drugs (ANDA) | 1 | 1.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 76 | 98.7% |
| Prescription drugs | 1 | 1.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Tranexamic acid | 1 | 39 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 73 | 94.8% |
| Liquid | 3 | 3.9% |
| Injection, solution | 1 | 1.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Antifibrinolytic Agent | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Arsenic trioxide | 14593-936 | Powder | Bulk ingredients | February 23, 2026 |
| Zoledronic acid | 14593-942 | Powder | Bulk ingredients | February 9, 2026 |
| Sodium nitroprusside | 14593-909 | Powder | Bulk ingredients | December 25, 2025 |
| Ropivacaine hydrochloride | 14593-907 | Powder | Bulk ingredients | November 21, 2025 |
| Tapinarof | 14593-953 | Powder | Bulk ingredients | November 19, 2025 |
| Dydrogesterone | 14593-954 | Powder | Bulk ingredients | July 24, 2025 |
| Benazepril hydrochloride | 14593-952 | Powder | Bulk ingredients | February 5, 2025 |
| Lenacapavir sodium | 14593-955 | Powder | Bulk ingredients | January 5, 2025 |
| Hydroxyzine pamoate | 14593-951 | Powder | Bulk ingredients | December 20, 2024 |
| Tranexamic Acid | 14593-318 | Injection, solution | Generic drugs (ANDA) | October 28, 2024 |
| Atazanavir sulfate | 14593-806 | Powder | Bulk ingredients | December 26, 2023 |
| Etodolac | 14593-875 | Powder | Bulk ingredients | December 25, 2023 |
| Memantine hydrochloride | 14593-870 | Powder | Bulk ingredients | December 25, 2023 |
| Dronedarone hydrochloride | 14593-866 | Powder | Bulk ingredients | December 25, 2023 |
| Busulfan | 14593-865 | Powder | Bulk ingredients | December 25, 2023 |
| Zolmitriptan | 14593-863 | Powder | Bulk ingredients | December 25, 2023 |
| Felbamate | 14593-862 | Powder | Bulk ingredients | December 25, 2023 |
| Esomeprazole sodium | 14593-857 | Powder | Bulk ingredients | December 25, 2023 |
| Zileuton | 14593-854 | Powder | Bulk ingredients | December 25, 2023 |
| Dolasetron mesylate | 14593-849 | Powder | Bulk ingredients | December 25, 2023 |
| Irinotecan hcl | 14593-828 | Powder | Bulk ingredients | December 25, 2023 |
| Gemcitabine hcl | 14593-827 | Powder | Bulk ingredients | December 25, 2023 |
| Protriptyline hcl | 14593-825 | Powder | Bulk ingredients | December 25, 2023 |
| Foscarnet sodium | 14593-925 | Powder | Bulk ingredients | December 22, 2023 |
| Fingolimod hydrochloride | 14593-902 | Powder | Bulk ingredients | December 22, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.